Human papillomavirus (HPV) in atypical squamous cervical cytology: The invader HPV test as a new screening assay

Journal of Clinical Microbiology

Volumn 46, Issue 3, 2008, Pages 869-875

  Wong, Anna K ^a   Chan, Raymond C K ^a   Nichols, W Stephen ^a   Bose, Shikha ^a,b  

^a BURNS AND ALLEN RESEARCH INSTITUTE   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONTROLLED STUDY; DNA EXTRACTION; GENOTYPE; HUMAN; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; WART VIRUS;

CARCINOMA, SQUAMOUS CELL; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; DNA PROBES; DNA, VIRAL; FEMALE; HUMANS; MASS SCREENING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; SPECIES SPECIFICITY; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

HUMAN PAPILLOMAVIRUS;

EID: 40749135057     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01424-07     Document Type: Article

References (28)

1. Reference deleted.
2. Castle, P. E., D. Solomon, M. Schiffman, and C. M. Wheeler for the ALTS Group. 2005. Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities. J. Natl. Cancer Inst. 97:1066-1071.
3. Reference deleted.
4. Crum, C. P., D. R. Genest, J. F. Krane, C. Hogan, D. Sun, B. Bellerose, E. Kostopoulou, and K. R. Lee. 1999. Subclassifying atypical squamous cells in thin-prep cervical cytology correlates with detection of high-risk human papillomavirus DNA. Am. J. Clin. Pathol. 112:384-390.
5. Davey, D. D., M. H. Neal, D. C. Wilbur, T. J. Colgan, P. E. Styer, and D. R. Mody. 2004. Bethesda 2001 implementation and reporting rates: 2003 practices of participants in the college of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch. Pathol. Lab. Med. 128:1224-1229.
6. Eskridge, C., W. P. Begneaud, and C. Landwehr. 1998. Cervicography combined with repeat Papanicolaou test as triage for low-grade cytologic abnormalities. Obstet. Gynecol. 92:351-355.
7. Evans, M., C. Adamson, and J. L. Papille. 2006. Distribution of human papillomavirus types in thinprep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes. Cancer 106:1054-1064.
8. Gage, J. C., V. W. Hanson, K. Abbey, S. Dippery, S. Gardner, J. Kubota, M. Schiffman, D. Solomon, and J. Jeronimo for the ASCUS LSIL Triage Study (ALTS) Group. 2006. Number of cervical biopsies and sensitivity of colposcopy. Obstet. Gynecol. 108:264-272.
9. Ho, G. Y., R. Bierman, L. Beardsley, C. J. Chang, and R. D. Burk. 1998. Natural history of cervicovaginal papillomavirus infection in young women. N. Engl. J. Med. 338:423-428.
10. Jones, B. A., and D. D. Davey. 2000. Quality management in gynecologic cytology using interlaboratory comparison. Arch. Pathol. Lab. Med. 124:672- 681.
11. Jones, H. W. 1995. The Bethesda System. Cancer 76(Suppl.):1914-1918.
12. Khan, M. J., P. E. Castle, A. T. Lorincz, S. Wacholder, M. Sherman, D. R. Scott, B. B. Rush, A. G. Glass, and M. Schiffman. 2005. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J. Natl. Cancer Inst. 97:1072-1079.
13. Kobelin, M. H., C. D. Kobelin, L. Burke, P. Lavin, J. M. Niloff, and Y. B. Kim. 1998. Incidence and predictors of cervical dysplasia in patients with minimally abnormal Papanicolaou smears. Obstet. Gynecol. 92:356-359.
14. Londesborough, P., L. Ho, G. Terry, J. Cuzick, C. Wheeler, and A. Singer. 1996. Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int. J. Cancer 69:364-368.
15. Mahmud, S. M., and E. L. Franco. 2004. An overview of epidemiological and public health research on HPVs. Papillomavirus Rep. 15:121-123.
16. Malik, S. N., E. J. Wilkinson, P. A. Drew, B. B. Bennett, and N. S. Hardt. 1999. Do qualifiers of ASCUS distinguish between low- and high-risk patients? Acta Cytol. 43:376-380.
17. Munoz, N., F. X. Bosch, S. de Sanjose, R. Herrero, X. Castellsaqué, K. V. Shah, P. J. Snijders, and C. J. Meyer for the International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. 2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N. Engl. J. Med. 348:518-527.
18. Parkin, D. M., P. Pisani, and J. Ferlay. 1999. Global cancer statistics. CA Cancer J. Clin. 49:33-64.
19. Poljak, M., I. J. Marin, K. Seme, and A. Vince. 2002. Hybrid Capture II HPV test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail. J. Clin. Virol. 25(Suppl. 3):S89-S97.
20. Quddus, M. R., C. J. Sung, M. M. Steinhoff, S. C. Lauchlan, D. B. Singer, and M. L. Hutchinson. 2001. Atypical squamous metaplastic cells. Cancer 93:16-22.
21. Schoolland, M., G. F. Sterrett, S. A. Knowles, K. M. Mitchell, and J. J. Kurinczuk. 1998. The "inconclusive-possible high grade epithelial abnormality" category in Papanicolaou smear reporting. Cancer 84:208-217.
22. Sherman, M. E., D. Solomon, and M. Schiffman. 2001. Qualification of ASCUS: a comparison of equivocal LSIL and equivocal HSIL cervical cytology in the ASCUS LSIL Triage study (ALTS). Am. J. Clin. Pathol. 116:386-394.
23. Slawson, D. C., J. H. Bennett, L. I. Simon, and J. M. Herman for the Harrisburgh Area Research Network. 1994. Should all women with cervical atypia be referred for colposcopy: a HARNET study. J. Fam. Pract. 38:387-392.
24. Solomon, D., M. Schiffman, and R. Tarrone. 2001. Comparison of three management strategies for patients with atypical squamous cells of undetermined significance. J. Natl. Cancer Inst. 93:293-299.
25. Walboomers, J. M., M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer, K. V. Shah, P. J. Snijders, J. Peto, C. J. Meijer, and N. Muñoz. 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189:12-19.
26. Wallin, K. L., F. Wiklund, T. Anstrom, F. Bergman, U. Stendahl, G. Wadell, G. Hallmans, and J. Dillner. 1999. Type specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N. Engl. J. Med. 341:1633-1638.
27. Wright, T. C., Jr., A. Lorincz, D. G. Ferris, R. M. Richart, A. Ferenczy, I. Meilzynska, and L. Borgatta. 1998. Reflex human papillomavirus deoxyribonucleic acid testing in women with abnormal Papanicolaou smears. Am. J. Obstet. Gynecol. 178:962-966.
28. Zuna, R. E., R. A. Allen, W. E. Moore, Y. Lu, R. Mattu, and S. T. Dunn. 2007. Distribution of HPV genotypes in 282 women with cervical lesions: evidence for three categories of intraepithelial lesions based on morphology and HPV type. Mod. Pathol. 20:167-174.